The thesis: the name is a container, and it holds whatever the quarter files

Every Take in this series has assumed, somewhere underneath its argument, that a product is the document filed for it: that the panel is the product in written form, and that grading the panel is grading the thing. The mouthwash shelf is where that assumption meets the unit it actually has to survive, which is not the panel but the name. The buyer does not shop for a filing. He shops for a name; he asks for it by name, he reorders it by name, his subscription renews a name, his memory files a dentist’s recommendation under a name, and the loyalty every brand on the shelf is buying is loyalty to a name. The Card’s record, read as a record of panels, is a shelf in good order: filings complete, actives dosed, directions printed, the federal registry doing its whole job. Read as a record of names, the same shelf is a set of containers whose contents change while the label on the container does not, and this issue argues that the second reading is the one that reaches the buyer, because the name is the only part of the product that travels. The panel stays on the bottle and in the registry. The name goes to the shelf, the basket, the bathroom and the reorder, carrying a warrant it has not earned: that what stands under it today is what stood under it when the buyer last checked.

The container’s capacity is the record’s most startling property, and the shelf’s centre exhibit states it in three filings. Under the name Crest Pro-Health stand three records that share nothing but the banner. Complete Clean, the variant the desk graded at 83, files cetylpyridinium chloride at 0.07%, antigingivitis and antiplaque, in a vehicle with no alcohol at all. Intense, under the same name, files the same active at 0.05%, a weaker dose of the same drug, dissolved in 15% alcohol, which is to say it reverses the graded variant’s posture on the shelf’s most-shopped axis while keeping its name. Advanced, under the same name again, changes the drug: sodium fluoride 0.02% is the filed active, a different job entirely, and the CPC that headlines the family’s other records rides in this one undosed, in the inactive ingredients, present as an ingredient and absent as a claim. A buyer who has learned that Crest Pro-Health is the alcohol-free CPC rinse, which is the truest single sentence the name supports, can pick up a bottle of Crest Pro-Health that is weaker, alcoholic and built on a different active, and every word he learned is still on the label, in the same order, in the same colours. The words that would correct him, Complete Clean, Intense, Advanced, are printed, and the record section will give the other side its full hearing on that point. What the thesis maintains is narrower and harder: the name, the unit the buyer actually carries, warrants nothing, because it is consistent with records that contradict each other on dose, on vehicle and on drug.

The capacity is not one maker’s habit; it is the shelf’s grammar, and the Card’s other names conjugate it. Listerine’s name holds two numbers for the same fact: Cool Mint files at 21.6% alcohol, and the Original sibling, the founding bottle of the house, files at 26.9%, so the sentence “Listerine is a 21.6% alcohol rinse” and the sentence “Listerine is a 26.9% alcohol rinse” are both true, of the name, and therefore neither is a fact about anything a buyer can hold. ACT’s case is the subtlest, because its graded record is the shelf’s most honest: the Anticavity variant prints its zero alcohol, and the zero is real, and the Card prints the zero’s address precisely, it belongs to the variant and not the brand, the family filing alcohol elsewhere on the same shelf. Even the shelf’s best name is a container; the zero is a property of one filing inside it. TheraBreath’s container holds a category: the Fresh Breath flagship is a cosmetic, with no Drug Facts panel at all, and its drug siblings, Healthy Gums and Deep Clean, file real panels, Deep Clean’s CPC at 0.1% the strongest on the extended shelf, so the name spans the exact line the whole filing system exists to draw, drug on one side and cosmetic on the other, and the flagship’s copy walks the authority of the filed side over to the unfiled one. CloSYS contributes the container in its purest form: its working ingredient is itself a name, Cloralstan, a trademark standing where the number belongs, a container inside the container, its concentration printed nowhere in the documents the desk could read. Five names, five mechanisms, one grammar: what the name holds is decided per filing, per quarter, per variant, and the name gives no notice when the contents change their dose, their vehicle, their drug or their category.

The control experiment stands at the shelf’s end, and it is the reason this issue trusts its own thesis. Colgate Peroxyl is the one name on the shelf that contains exactly its record. It calls itself a Mouth Sore Rinse, which is what it is: hydrogen peroxide at 1.5%, a complete and honest panel, alcohol free, dosed at 10 mL for at least a minute as often as four times a day, and capped by its own panel at seven days of use. Name and record coincide, perfectly, and the desk sent it home, because a seven-day course is not a daily rinse and the Card grades a daily shelf. The control proves the thesis in both directions. Where the name is honest, the name is legible: a buyer can learn Peroxyl once and be right forever, because the container was built to hold one thing and says so. Where the names are capacious, no learning survives: the buyer’s knowledge attaches to a word, and the word’s contents are a filing decision he is not party to. The shelf, in other words, punishes exactly the names that behave the way this issue asks names to behave, and rewards the capacious ones with the loyalty of buyers who believe they have learned something. That inversion, and not any single variant’s existence, is the shelf’s offence, and the cost section prices it. First, the record, entire and in the Card’s own order, because every claim above and below this paragraph is a claim about eight filings and the reader is owed them undistilled.

The record: eight filings, six names, and what stands in each container

The shelf as the desk graded it, on the buyer-legible documents, with the Card’s disclaimer standing at the head of the record because this issue repeats the Card’s figures and inherits its boundary: efficacy is graded nowhere on the Card and nowhere here, the desk rinsed nothing and treats no gum, and the bases are honesty out of 30, the active record out of 20, fit and format out of 20, value out of 15 and graded, for the first time on a shelf in this run, on the second price a bottle charges, the printed dose’s cost per month, and longevity and service out of 15. ACT Anticavity won at 87 (25/19/18/15/10), and its record is the shelf’s best filing behaviour: sodium fluoride 0.05%, with the fluoride ion it delivers printed beside it at 0.02% w/v, the second number costing the maker nothing and most labels omitting it. The dose is 10 mL, swished one minute, once daily, and the bottle meters it to a fill line, an instrument printed on the container rather than an estimate left to the buyer. The vehicle carries zero alcohol, the age floor is 6, the price is $3.99 for 18 fluid ounces at Target, and the month at the printed dose is $2.25, the cheapest month on the shelf by a distance the record section will make plain. Its asterisks are the Card’s and both are printed rather than smoothed: the CPC of its cousin rinses rides undosed in this filing’s inactive list, the shelf’s family habit in miniature, and the ADA seal is claimed in the maker’s copy with the desk unable to confirm it, the logo reported removed from current packaging and the product absent from the Association’s own search as the desk read it. What matters for this issue stands in front of the asterisks: everything graded about ACT is a property of the Anticavity variant, printed by the Card in those words, the zero alcohol belonging to the variant and not the brand. The shelf’s best container is still a container, and its best filing is honest about which compartment it is honest in.

Listerine Cool Mint stands second at 85 (24/20/16/12/13), carrying the shelf’s maximum active record, and the filing is the original antiseptic record entire: four essential oils at four printed percentages, eucalyptol 0.092%, menthol 0.042%, methyl salicylate 0.060% and thymol 0.064%, in 21.6% alcohol, dosed 20 mL for 30 seconds twice daily, age floor 12, priced $7.99 for the 1.5-litre bottle at Target, $6.39 the month, ADA Accepted on the filed label, the desk finding not one contested number in the whole document. The container problem arrives on schedule, in the Card’s own sentence: the Original sibling, the founding variant the name was built on, files at 26.9% alcohol, so the house’s name spans five points of alcohol across its first two bottles, and the desk’s count of the shelf’s alcohol numbers, printed as a number on 2 of 8, is two filings of the same name at the same figure, the pair of them Listerine’s 21.6. Alongside it stands the shelf’s emblematic address fact: the maker’s own product page prints none of the panel, no active, no percentage, no alcohol figure, on the page of the most documented rinse in the category’s history. The filing is immaculate and the filing is elsewhere. That is No. 22’s anatomy and No. 34’s, and the honesty section explains why this issue is nevertheless not theirs: the panel does travel with the bottle as sold, filed and labelled complete, and the failure this shelf adds stands above the address, in the word the buyer says at the shelf, which names both the 21.6 bottle and the 26.9 one and distinguishes neither.

Equate Blue Mint stands third at 84 (24/19/16/13/12), and it is the record’s standing reproach to the container theory’s lazy version, because here a second name holds the first name’s record entire and says so in the only court that grades it. The store brand’s Drug Facts reproduce the brand antiseptic’s filing without a changed figure: the same four actives at the same four percentages on the same 21.6% alcohol, the same directions, the same warnings, the same age floor, with two additions the brand’s filing lacks, its own ADA Accepted panel printed on its front and a satisfaction guarantee, replace it or refund it, that the brand’s document nowhere offers. Its use line is narrower and the narrowness is scored in its rows rather than hidden: it claims the plaque-to-gingivitis road where the brand claims gingivitis itself. The card stands pill-less, no buy pill, because Walmart’s own product page would not load for the desk, and the price the buyer can actually pay stands in the record from the filing’s Target twin, the same document sold as up & up at $6.99 for two 1.5-litre bottles, its month about $2.80. Hold the three facts together and the shelf’s arithmetic of names collapses: the filing graded 85 under Listerine’s name is graded 84 under Equate’s, one point for the narrower use line, and the document a buyer is loyal to when he is loyal to the 85 does not belong to the 85’s name at all. It belongs to the registry, where it is filed twice, and the second filing carries the better guarantee. This issue’s sibling argument returns here in the honesty section; the record’s sentence is simpler. On this shelf, a name can be duplicated entire, and the copy outranks nothing, because the copy was never the name’s to begin with.

Crest Pro-Health Complete Clean stands fourth at 83 (22/17/18/14/12), graded on its own filing and graded fairly: CPC 0.07% claiming antigingivitis and antiplaque, alcohol free, dosed across the mouth’s ordinary day, age floor 6, priced $4.99 the litre at Oral-B, the maker’s own store, $5.99 the month, $6.00 at Walgreens, carrying a satisfaction guarantee on the maker’s page and no ADA claim anywhere in the maker’s copy, a restraint the Card credits and this issue notes as the name’s one quiet compartment. Then the Card prints the family hazard entire, and this issue elevates it from hazard to thesis, because it is the container with its lid off. Under the same name, Intense files CPC at 0.05% in a 15% alcohol vehicle; Advanced files sodium fluoride 0.02%, changing the active’s job from the gum line to the enamel, with the family’s headline CPC undosed in the inactive list. Even the name’s guarantee knows the container’s secret: the satisfaction promise inside the Crest name is printed for “this formula”, the maker’s own words declining to warrant the name and warranting a filing instead. No other sentence in the record concedes this issue’s argument as completely, in the maker’s own hand, on the maker’s own page. The desk graded the variant in front of it at 83 and the grade stands; what cannot stand is any sentence of the form “Crest Pro-Health is” followed by a property, because the name is consistent with a stronger and a weaker dose, with sobriety and with 15% alcohol, with an antiseptic and with a fluoride rinse, and a subject consistent with everything predicates nothing.

The shelf’s lower half is the container’s other mechanisms, each distinct. TheraBreath Fresh Breath stands fifth at 67 (21/9/15/9/13), a cosmetic rinse with no Drug Facts panel, priced $7.69 for 16 fluid ounces at Target and $9.76 the month at its printed dose, its named ingredient, sodium chlorite, dosed nowhere in the documents the desk could read, its ADA acceptance standing in the maker’s copy and scoped, read closely, to bad breath. The dose discipline dissolves as the record descends: the label prints 10 mL rinsed and gargled for 90 seconds, twice daily, once daily for ages 12 to 17, while the maker’s how-to copy renders the same dose as a capful for a minute with a 30-second gargle, and the headline claim performs the shelf’s neatest arithmetic, “fights bad breath for 12 hours” becoming 24 in the bullets by the twice-daily schedule, a duration doubled by division of the day. And behind the unfiled flagship stand the filed siblings, Healthy Gums and Deep Clean, drug rinses with real panels, Deep Clean’s CPC at 0.1% the strongest CPC figure on the extended shelf, lending the name an authority its flagship has not filed for. The container here holds a category boundary: drug and cosmetic under one banner, the banner doing the evidentiary work the flagship’s missing panel cannot. CloSYS Ultra Sensitive stands sixth at 60 (19/8/14/8/11), priced $13.99 for 32 fluid ounces at Target, its month $13.31 computed on the retail-printed half-ounce dose and flagged by the Card as computed so, because the maker’s documents as read print no dose volume at all, 30 seconds morning and evening and the quantity left to a retailer’s page. Its ingredient list is four lines long and this issue has already named its centre: water, Cloralstan, trisodium phosphate, citric acid, Cloralstan a trademark for stabilised chlorine dioxide whose concentration is printed nowhere, the working ingredient itself a name holding an unpublished number, the container principle operating at the level of the molecule’s label. Its flavour arrives by a dropper of mineral oil and peppermint oil, the buyer dosing the taste of a product whose active he cannot dose at all, and its ADA standing lives in package copy scoped to bad breath, which the desk found in no filing it could open.

SmartMouth Original stands seventh at 59 (20/9/13/5/12), and its container is a schedule. The system is two solutions mixed at first use, priced $19.99 the set at the maker’s store, and the maker’s page is, to its credit and the record’s instruction, the shelf’s most forthcoming shop window: both solutions’ full ingredient lists are printed, and the mixing dose is printed exactly, Solution 1 to the 10 mL mark and Solution 2 to the 20 mL mark, 30 seconds, twice daily. What no document prints is a percentage for either working ingredient, sodium chlorite and zinc chloride, although the brand demonstrably prints a percentage when the law asks it to: its Clinical sibling files CPC 0.05% when mixed, in the drug channel where percentages are compulsory. The page even answers its own alcohol question, “yes, alcohol-free”, while Solution 2’s printed list includes benzyl alcohol, an answer filed under the name’s colloquial meaning against the document’s own contents. And the set is sold as one month’s supply that empties in about 24 days at the printed dose, making its month $25.36, the shelf’s dearest by more than ten dollars over the runner-up mechanism. The container’s final mechanism is thus time: the name’s own quantity word, month, does not survive contact with the name’s own printed dose. Colgate Peroxyl closes the record sent home, no pill and no rows, its facts already given in the thesis: peroxide 1.5%, the complete honest panel, the seven-day cap in its own words, $11.99 at Target. The desk’s ruling stands and this issue adopts it as the control: the filing retires the product from a daily shelf, and it is the only retirement on the shelf that the product’s own name announces in advance.

The counts, gathered once, in the Card’s words, because this issue will spend the rest of its length inside them. A Drug Facts panel with actives and percentages reachable from the maker’s own product page: 0 of 8, the documents living in the FDA filings and on the bottles while the makers’ pages carry the marketing where the document should be. Alcohol printed as a number: 2 of 8, both Listerine filings, both 21.6%. A dose printed with volume and time: 7 of 8, CloSYS the exception, its time printed and its volume in no maker document the desk could read. An ADA seal claimed: 5 of 8, scoped three ways, filed on a label, claimed in copy, and standing in package copy, three different addresses for the same two letters. The month’s spread: $2.25 to $25.36, $23.11 apart, for the same daily act at the printed doses. Read the counts as an inventory of the name’s working conditions and they describe a shelf where everything checkable is checked and filed, at an address the buyer is not sent to, under names consistent with contradiction, duplication, category drift and a month of 24 days. The record is not a scandal of missing documents. It is a scandal of units: the documents are filed per variant, the loyalty is collected per name, and the two ledgers have never been reconciled in the buyer’s hearing.

The cost: the swap, the renewal, and the month of 24 days

The container’s cost is paid at three tills, and the first is the shelf itself, in the seconds the decision actually takes. A variant word is a real word, printed, and the other side will make its case from that fact; the cost section’s answer begins by agreeing and then timing it. The purchase this shelf sells is a repeat purchase made at speed: a replenishment, chosen from a thumbnail, a subscription page or a two-metre shelf of near-identical blue and green bottles, by a buyer who has already decided, weeks or months earlier, which rinse he uses. What he decided was a name; it could not have been anything else, since the name is the only part of the product that fits in a memory, a sentence to a partner, a note in a phone. The variant word that distinguishes a 0.07% alcohol-free filing from a 0.05% filing in 15% alcohol is, on the bottle, the smallest typographic event in the design, subordinated by every rule of package hierarchy to the banner it qualifies; in the online listing it is a tail on a title; in the subscription it is frequently nothing at all, the renewal renewing the name and the warehouse honouring whichever variant the name currently fronts. The swap, when it happens, is silent and total: the buyer receives a weaker dose of the same drug in a vehicle that reverses the property he chose the product for, and no document he was shown announced the change, because the change occurred inside the container, and containers do not file change notices. The desk’s own family hazard sentence prices the swap exactly: a buyer who wanted the alcohol-free CPC rinse carries home a different drug posture under the right name, and discovers it, if he discovers it, at the burn.

The second till is the month’s money, where the container’s vagueness stops being semantic and becomes arithmetic. The Card’s value basis, the printed dose’s cost per month, exists because the bottle’s price is the shelf’s least honest number, and the month exposes what the name conceals twice over. Once, across the shelf: the same daily act costs $2.25 under ACT’s name and $25.36 under SmartMouth’s, with the identical filing to the shelf’s second place available at about $2.80 under a store’s name, a spread of $23.11 that no property of the names predicts and only the filings explain. And once, inside a single name: SmartMouth sells its set as one month’s supply whose printed dose empties it in about 24 days, so the name’s own unit of quantity is overstated by a fifth against the name’s own instructions, and the buyer’s calendar, set by the label, runs six days a month ahead of his supply. A month is the one word on the shelf that sounds like a measurement. Measured, it is the least reliable word in this paragraph, and it is reliable nowhere the buyer cannot divide a volume by a dose, which is to say it is reliable only in the filing, the address he was not sent to.

The third till is ours, and the series prints its own costs when it finds them. A ranking must rank something, and the container forces the choice this Card made and this issue endorses as doctrine: rank the variant, cite the filing, and let the name appear only as the filing’s address. The alternative is visible in every index and listing the shelf generates: a search for the name returns the name’s pages, where the properties of three incompatible filings are blended into copy that is true of each in part and of none in whole, the maker’s own guarantee retreating, in its careful words, to “this formula”. The buyer’s version of the same cost is trust’s bookkeeping. Loyalty to a name that has silently changed its dose, its vehicle or its drug is not loyalty rewarded or betrayed in any way the buyer can audit, because the audit requires the filing and the filing requires the registry, and a trust that can only be audited in a federal database is, in the buyer’s actual life, unaudited. What the container sells, finally, is the feeling of a settled decision, a name learned once and reordered forever, and what it delivers is a subscription to the maker’s filing calendar. The desk’s scores stand, every one of them, on the variants in front of it. This issue’s ruling is the same sentence read at the buyer: a name that can hold a 0.07% filing and a 0.05% one, sobriety and 15% alcohol, a drug and a cosmetic, is not a product with variants. It is a shelf with a banner, and it should be shopped as one.

The other side, stated fairly

The case against this issue is a good one and it deserves its strongest form, because the container is not a conspiracy; it is a convention, and conventions usually encode a reason. First, the variant words are printed. Complete Clean, Intense and Advanced stand on their bottles in the maker’s type, the panels are filed complete and labelled on every unit sold, and a buyer who reads the bottle in his hand gets exactly the record he chose. Names are ranges in every category a man buys: a car’s name spans engines, a phone’s spans storage, a jacket’s spans sizes, and nobody argues the name is a fraud because the specification lives one level down. The filing system, on this account, works perfectly; the buyer’s unit of speech is simply coarser than the regulator’s unit of record, and the coarseness is the buyer’s convenience, not the maker’s offence. Second, the family is a finding aid with real economies behind it. A house that files three rinses under one banner shares research, manufacturing discipline and a reputation it must protect across all three; the flagship’s record is not stolen authority but the family’s common capital, and the buyer who trusts the banner is trusting something real, the house’s incentive not to file a bad record under its own best-known word. Variant breadth, third, answers genuine difference: the alcohol-free buyer and the buyer who wants the burn are different men with different mouths, fluoride and CPC are different jobs honestly labelled, and a container holding different tools is a toolbox, not a deception. A shelf where every formulation needed its own name would be a shelf of a thousand forgettable words, and the buyer would be worse served, not better.

The desk concedes the frame and disputes the shelf. The variant word is printed, yes, and the reading buyer is protected, yes, and the protection fails exactly where this shelf’s purchases happen: at speed, from memory, and by renewal, the three channels the cost section priced, in none of which the buyer holds the bottle before the decision is made. The car analogy fails on the shelf’s own evidence, and it is worth being precise about why: a car’s name spans engines that differ in degree, and no engine in the range reverses the property the range is bought for; this shelf’s banner spans a reversal, the same name filing the category’s alcohol-free posture and a 15% alcohol vehicle, a stronger active and a weaker one, on the axis the buyer is shopping. A toolbox holds tools that do different jobs; Complete Clean and Intense claim the same job, antigingivitis CPC rinsing, at different strengths in opposite vehicles, which is not a toolbox but a relabelling of the dose. The family-capital argument is the strongest of the three, and TheraBreath is its refutation in the record: the flagship’s copy does not merely stand near the siblings’ panels, it borrows their authority across a category line, a cosmetic wearing a drug family’s credentials, its ADA scope readable only in the fine grain of the claim. Common capital is capital; spent by an unfiled product on the strength of filed siblings, it is the container doing evidentiary work, and that is the point at which a finding aid becomes a warrant. What survives of the other side, and it is not nothing: the filings themselves are complete, the law’s ledger is honest, no maker on this shelf was caught filing a false record, and the variant words, read, do distinguish the records. The offence this issue grades is narrower than fraud and, for a buyer, larger: the unit of loyalty and the unit of record have come apart, the makers collect on the first and file on the second, and the shelf’s best documents all stand in the ledger nobody is sent to read.

The shelf as ranked: what each name covers

The neighbouring shelves inherit the container rule unchanged, because the mechanism is a shelf grammar and not a rinse’s habit. Verdict Card No. 118 graded brushes whose famous names ride in handles turned by other hands, and No. 105 graded a cream sold by a bar whose recipe the tin does not repeat; in each case the desk graded the object’s own record and printed the name’s distance from it, and in each case the buyer’s defence is the same as this shelf’s: the record exists, in a filing, a specification or a maker’s document, and it is attached to the variant, the model, the formula, the address one level below the word on the front. What Card No. 122 adds to the doctrine, and what this issue exists to print, is the demonstration that the distance can be incompatible rather than merely loose: not a name that approximates its record, but a name consistent with records that contradict each other on dose, vehicle, drug and category. Approximation is the ordinary tax on language. Contradiction is a different instrument, and it should be shopped with a different instrument: the panel, in the variant, every time.

What this page does not claim

The source boundary first. Every score, row, price, percentage, count and name in this issue is Verdict Card No. 122’s, read entire before writing and reproduced as the Card prints it: ACT Anticavity 87, Listerine Cool Mint 85, Equate Blue Mint 84, Crest Pro-Health Complete Clean 83, TheraBreath Fresh Breath 67, CloSYS Ultra Sensitive 60, SmartMouth Original 59, Peroxyl sent home without a card’s rows, and the counts of 0 of 8 panels on makers’ pages, alcohol as a number on 2 of 8, doses on 7 of 8, the seal claimed on 5 of 8 and the $23.11 spread exactly as the Card states them. No figure has been re-derived, re-based or corrected here, and no claim is made past the Card’s own: who manufactures any maker’s or store brand’s rinse is not in the record and is not guessed at, the ADA standings are the Card’s, claimed, filed and unconfirmed as it prints them, and the identical-filing finding is a finding about printed Drug Facts, which is the only identity this desk grades. Efficacy is claimed nowhere, here or on the Card: whether any of these rinses works is outside both documents, and any reader who takes a score in this issue as a verdict on what a rinse does in a mouth has read a filing grade as a clinical one, which the Card’s disclaimer and this section both refuse. The date boundary is the Card’s: prices and filings stand as of its check date printed in its header, formulations are filed per quarter and can be refiled, and a container argument is, if anything, strengthened by the possibility, since it is precisely the refiling that the name does not announce.

The centre was this issue’s to choose, and the choice is defended here because the record offered three. The filing-as-shelf centre, the registry as the true shop and the store as its rumour, is real and is argued inside this issue’s record and cost sections, but it is No. 22’s and No. 34’s ground, the document’s address, and it describes where truth lives rather than what the buyer holds. The identical-copy centre, Equate’s 84 outranking its own verification, the copy graded on a document its seller’s page would not show, is the record’s sharpest single exhibit and stands in the record section at full length; as a centre it explains one card, and the shelf’s other five names fail in five other directions. The container centre was chosen because it is the only one that predicates all eight filings: Crest’s three records, Listerine’s two numbers, ACT’s variant-bound zero, TheraBreath’s borrowed category, CloSYS’s trademarked active, SmartMouth’s 24-day month, Equate’s duplicated document and Peroxyl’s honest retirement are one mechanism at eight addresses, the name holding whatever is filed under it, and an issue’s centre should be the claim that survives the whole of its own record. The title is defended on the same ground: “the record” is the family’s word for the filed document across this series, and the sentence the title prints is the shelf’s own arithmetic, one name, three records under Crest’s, two numbers under Listerine’s, the name being the only term in either sentence that stays constant. A title naming the panel or the filing instead was weighed and set aside: those instruments behaved, on this shelf, exactly as they should, and an issue’s title is owed to the instrument that did not.

The kinship, printed with its working, because this issue’s family was a genuine choice and the rejected candidates deserve their reasons in the open. The parent is No. 5, the name is not the number, argued from the fragrance ranking, where a house’s name stood in place of the figure the buyer needed and the bottle would not give. This issue’s question is that question one filing later: the numbers now exist, filed, exact and public, and the name stands over them, plural and incompatible, so that the failure is no longer that the name substitutes for a missing number but that it survives any number filed beneath it. That standing-over is an extension of No. 5’s argument and is marked as this issue’s own; No. 5’s shelf never had the numbers to contradict its names, and this one does, and the extension is the distance between those two shelves. The grandparent is No. 2, a number on the bottle, and the descent is not this issue’s invention: No. 5’s own Next paragraph treats No. 2 as the ancestor case of which its scent shelf is the purest instance, and this shelf is that case’s third generation, No. 2 asking whether one number stands behind a name, No. 5 answering that the name replaces it, and No. 35 recording that the name now outlasts several numbers at once. The sibling is No. 11, the list is not the bottle, whose own Next paragraph prints that No. 5 governs the name half of its shelf, the named material itemised on none of its bottles: the name-line’s second case under the same parent, and the resemblance is structural. There the name stood where a document should have itemised and did not; here the name stands over documents that itemise completely and disagree, the same jurisdiction at the opposite evidence, which is what a sibling in this family is. The close calls, with their reasons. No. 22 as parent was the hardest rejection: its anatomy, the panel filed in the registry and absent from the shop, is this shelf’s 0 of 8 exactly, but that anatomy is inherited in No. 22’s own record from Nos. 18 and 13, No. 34 argued the document’s address one issue ago, and this shelf’s panels do travel with the bottle as sold, filed and labelled; the failure stands above the address, in the name, which is No. 5’s jurisdiction and not the address line’s. No. 34 as sibling fails on the document’s question: its promises stand off the page in brand copy, while this shelf’s promises stand in filings and on bottles, present and retrievable, and what fails is the unit above them. No. 18 as parent fails at its own border: its compulsion is what filed every number this issue quotes, the issue begins where the compulsion’s work ends, and nothing in a labelling law explains a cosmetic flagship borrowing its drug siblings’ standing. No. 14 fails on geography and language: this registry is domestic, these labels complete, nothing untranslated, and the name still does not settle the record. No. 6 as the sibling alternative was weighed and set aside on shape: its shelf’s failure is absence, the working material missing from the list, while this shelf’s names fail by containing, full to contradiction, and kinship in this family follows the shared parent and the failure’s direction, both of which point to No. 11. The photography stands as the head of this file records it: Card No. 122’s own frame, a shared grooming portrait, carried the way Nos. 32, 33 and 34 carried their Cards’ frames, the bank holding no mouthwash product photography of any kind, and an issue about labels and filings quoting its documents rather than photographing bottles it does not hold.

Questions, answered